NCT00528489View on ClinicalTrials.gov

Safety and Effectiveness of PENNVAX-B Vaccine Alone, With Il-12, or IL-15 in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
HIV Infections
Interventions
BIOLOGICAL

PennVax B

DNA vaccine containing the HIV genes Gag, Pol, and Env

BIOLOGICAL

IL-12

Cytokine injection

BIOLOGICAL

IL-15

Cytokine injection

Trial Locations (8)

10003

NY Blood Ctr./Union Square CRS, New York

10032

HIV Prevention & Treatment CRS, New York

10456

NY Blood Ctr./Bronx CRS, The Bronx

35294

Alabama Vaccine CRS, Birmingham

Unknown

San Francisco Vaccine and Prevention CRS, San Francisco

Brigham and Women's Hosp. CRS, Boston

3535 Market Street CRS, Philadelphia

Vanderbilt Vaccine CRS, Nashville

All Listed Sponsors
collaborator

HIV Vaccine Trials Network

NETWORK

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00528489 - Safety and Effectiveness of PENNVAX-B Vaccine Alone, With Il-12, or IL-15 in Healthy Adults | Biotech Hunter | Biotech Hunter